Azitra
Business Services · Connecticut, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
21 Business Park Dr, Branford, Connectic...Phone Number
(203) 646-6446Website
www.azitrainc.comRevenue
-Stock Symbol
AZTRIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
2
1
1
About Azitra
Azitra, Inc. is a clinical-stage biopharmaceutical company specializing in precision dermatology, with a focus on developing innovative therapies for a wide range of skin diseases. Founded in 2014 and headquartered in Branford, Connecticut, the company leverages advanced scientific approaches such as genetic engineering, proteomics, and microbiome research to create targeted treatments. Its core strategy involves the use of engineered proteins and live biotherapeutic products, including genetically modified bacteria designed to restore or enhance the skins natural functions. Azitra has built a proprietary platform that combines a large microbial library of over 1,500 bacterial strains with artificial intelligence and machine learning tools to identify and develop effective therapeutic candidates. The companys pipeline includes treatments for conditions such as Netherton syndrome, EGFR inhibitor-associated rash, and ichthyosis vulgaris. By focusing on the skin microbiome and engineeredRead more
Azitra Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Azitra your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Azitra recently announced quarterly report
Funding: Get notified immidiatlly once Azitra has new funding data
Click to see if Azitra had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Azitra, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Azitra has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Azitra launches new products
Congratulate Masked Content for being promoted to Masked Content at Azitra
Check out if Azitra is spiking on competitors!
Recommended Actions
Find VP level buyers at Azitra
Find more new buyers
Compare Similar Companies to Azitra
Compare insights from companies similar to Azitra, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Azitra is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Azitra is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Azitra.
Azitra financials insights
Gather financial insights about Azitra, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Debt
$2.1M
2019
Series A
$14M
2020
Debt
$150K
Series B
$17M
Azitra Tech Stack
A closer look at the technologies used by Azitra
Most Recent Scoops
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Earnings
Earnings, Finance
Left Company
Executive Move
Executive Moves, Left Company
Earnings
Azitra has reported cash and cash equivalents of $7.3 million for Q3 2024, ended September 30, 2024.
Earnings, Finance
Project
Financial Planning, Finance, Financial Strategy
Azitra News & Media
Azitra Announces Adjournment of 2026 Annual Meeting and Information for Reconvened Meeting
BRANFORD, Conn., June 4, 2026 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced its 2026 Annual Meeting, originally scheduled for and convened on June 4,...Azitra Announces Intention to Adjourn Annual Meeting and Reconvene Annual Meeting
BRANFORD, Conn., May 27, 2026 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced that it intends to convene its upcoming 2026 annual meeting of stockholders...AZTR: More Background on Cosmetic Opportunity - Zacks Small Cap Research
By John Vandermosten, CFA NYSE:AZTR READ THE FULL AZTR RESEARCH REPORT Azitra, Inc. (NYSE:AZTR) reported first quarter 2026 financial and operational results on May 13 th and provided a business update. For 2026 to date, Azitra has raised over $10 million in capital that will support the launch of a new indication in cosmetics and cosmeceuticals along with its other clinical programs. It has alsoNetherton Syndrome Market Set to Expand During the Forecast Period (2026-2036) as Novel Therapies Enter Development Pipeline | DelveInsight
LAS VEGAS, May 19, 2026 /PRNewswire/ -- The Netherton syndrome market size is expected to grow during the forecast period (2026–2036), primarily driven by the launch of upcoming therapies such as QRX003 (Quoin Pharmaceuticals), BCX17725 (BioCryst Pharmaceuticals), ATR-12 (Azitra), and...
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Azitra
Sign Up For FreeTo access detailed company insights
Azitra, Inc. is a clinical-stage biopharmaceutical company specializing in precision dermatology, with a focus on developing innovative therapies for a wide range of skin diseases. Founded in 2014 and headquartered in Branford, Connecticut, the company leverages advanced scientific approaches such as genetic engineering, proteomics, and microbiome... Read More
